 |
| Scientific Committee on Emerging and Newly Identified Health Risks |  |
|  |
 |  |
| |
Mandate
It shall provide opinions on questions concerning emerging or newly identified health and environmental risks and on
broad, complex or multidisciplinary issues requiring a comprehensive assessment of risks to consumer safety or public
health and related issues not covered by other Community risk assessment bodies.
Examples of potential areas of activity include potential risks associated with interaction of risk factors, synergic effects,
cumulative effects, antimicrobial resistance, new technologies such as nanotechnologies, medical devices including
those incorporating substances of animal and/or human origin, tissue engineering, blood products, fertility reduction,
cancer of endocrine organs, physical hazards such as noise and electromagnetic fields (from mobile phones, transmitters
and electronically controlled home environments), and methodologies for assessing new risks. It may also be
invited to address risks related to public health determinants and non-transmissible diseases.
Stakeholder dialogue procedure
Rules of procedures
Members Scientific Committees (CVs and Declarations)
Agenda Plenary Meetings
Minutes Plenary Meetings
Members Working Groups (Declarations)
Minutes + Agenda Working Groups
Questions
Opinions
Statements
See also:
Former Scientific Committees
Contact
Katja BROMEN
European Commission
Health & Consumer Protection DG
Directorate C: Public Health and Risk Assessment
Unit C7: Risk Assessment
Office: B232, 2/106
B-1049 Brussels
Tel (+32-2-29)85552
Fax: (+32-2-29)57332
E-mail: Sanco-Sc1-Secretariat@ec.europa.eu
| |
 |  |  |
|
|